Preclinical pharmacology of a lipophenol in a mouse model of light-induced retinopathy

[1]  G. Lenaers,et al.  Isopropyl‐phloroglucinol‐DHA protects outer retinal cells against lethal dose of all‐trans‐retinal , 2020, Journal of cellular and molecular medicine.

[2]  I. Bellezza.  Oxidative Stress in Age-Related Macular Degeneration: Nrf2 as Therapeutic Target , 2018, Front. Pharmacol..

[3]  H. Flynn,et al.  Stargardt macular dystrophy and evolving therapies , 2018, Expert opinion on biological therapy.

[4]  G. Aldini.  Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds , 2018, Free Radical Biology and Medicine.

[5]  Jian-xing Ma,et al.  A novel RPE65 inhibitor CU239 suppresses visual cycle and prevents retinal degeneration. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[6]  K. Tsunoda,et al.  Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy , 2018, Ophthalmology.

[7]  Frank G. Holz,et al.  Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial. , 2018, Ophthalmology.

[8]  B. Lam,et al.  Pharmacotherapy of retinal disease with visual cycle modulators , 2018, Expert opinion on pharmacotherapy.

[9]  Krzysztof Palczewski,et al.  Towards Treatment of Stargardt Disease: Workshop Organized and Sponsored by the Foundation Fighting Blindness , 2017, Translational vision science & technology.

[10]  P. Brabet,et al.  Fatty acid transport protein 1 regulates retinoid metabolism and photoreceptor development in mouse retina , 2017, PloS one.

[11]  Gregory P Tochtrop,et al.  Rational Tuning of Visual Cycle Modulator Pharmacodynamics , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[12]  Koh M. Nakagawa,et al.  Docosahexaenoic acid preserves visual function by maintaining correct disc morphology in retinal photoreceptor cells , 2017, Journal of Biological Chemistry.

[13]  J. Dunaief,et al.  Intraperitoneal injection of (−)-Epigallocatechin-3-gallate protects against light-induced photoreceptor degeneration in the mouse retina , 2017, Molecular vision.

[14]  R. Adelman,et al.  Novel therapeutics for Stargardt disease , 2017, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  Y. Koutalos,et al.  All‐trans retinal levels and formation of lipofuscin precursors after bleaching in rod photoreceptors from wild type and Abca4‐/‐ mice , 2017, Experimental eye research.

[16]  P. Brabet,et al.  Phloroglucinol protects retinal pigment epithelium and photoreceptor against all‐trans‐retinal–induced toxicity and inhibits A2E formation , 2016, Journal of cellular and molecular medicine.

[17]  S. Wolf,et al.  Fluorescence Lifetime Imaging in Stargardt Disease: Potential Marker for Disease Progression. , 2016, Investigative ophthalmology & visual science.

[18]  K. Palczewski,et al.  Molecular pharmacodynamics of emixustat in protection against retinal degeneration. , 2015, The Journal of clinical investigation.

[19]  K. Kaarniranta,et al.  Polyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related Diseases , 2015, Oxidative medicine and cellular longevity.

[20]  B. Blumberg,et al.  Visual Cycle Modulation as an Approach toward Preservation of Retinal Integrity , 2015, PloS one.

[21]  David S. Williams,et al.  A Comparison of Some Organizational Characteristics of the Mouse Central Retina and the Human Macula , 2015, PloS one.

[22]  W. Gordon,et al.  Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survival , 2015, Nature Communications.

[23]  B. Ji,et al.  Docosahexaenoic acid aggravates photooxidative damage in retinal pigment epithelial cells via lipid peroxidation. , 2014, Journal of photochemistry and photobiology. B, Biology.

[24]  M. Lagarde,et al.  Synthesis and Evaluation of Polyunsaturated Fatty Acid–Phenol Conjugates as Anti‐Carbonyl‐Stress Lipophenols , 2014 .

[25]  G. Aldini,et al.  Novel molecular approaches for improving enzymatic and nonenzymatic detoxification of 4-hydroxynonenal: toward the discovery of a novel class of bioactive compounds. , 2014, Free radical biology & medicine.

[26]  J. Sparrow,et al.  Light damage in Abca4 and Rpe65rd12 mice. , 2014, Investigative ophthalmology & visual science.

[27]  K. Tsubota,et al.  Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. , 2013, American journal of ophthalmology.

[28]  N. Lee,et al.  Phloroglucinol Attenuates Motor Functional Deficits in an Animal Model of Parkinson's Disease by Enhancing Nrf2 Activity , 2013, PloS one.

[29]  Ulrich Schraermeyer,et al.  Fundus autofluorescence in the Abca4(-/-) mouse model of Stargardt disease--correlation with accumulation of A2E, retinal function, and histology. , 2013, Investigative ophthalmology & visual science.

[30]  H. Rupasinghe,et al.  Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases , 2013, Oxidative medicine and cellular longevity.

[31]  S. Grégoire,et al.  Fatp1 Deficiency Affects Retinal Light Response and Dark Adaptation, and Induces Age-Related Alterations , 2012, PloS one.

[32]  M. Golczak,et al.  Retinal Photodamage Mediated by All‐trans‐retinal † , 2012, Photochemistry and photobiology.

[33]  M. Boulton,et al.  Cytotoxicity of All‐Trans‐Retinal Increases Upon Photodegradation † , 2012, Photochemistry and photobiology.

[34]  Lee R Ferguson,et al.  Modified protocol for in vivo imaging of wild-type mouse retina with customized miniature spectral domain optical coherence tomography (SD-OCT) device , 2012, Biological Procedures Online.

[35]  Vindhya Koppaka,et al.  Aldehyde Dehydrogenase Inhibitors: a Comprehensive Review of the Pharmacology, Mechanism of Action, Substrate Specificity, and Clinical Application , 2012, Pharmacological Reviews.

[36]  Y. Sauve,et al.  Dietary docosahexaenoic acid supplementation prevents age-related functional losses and A2E accumulation in the retina. , 2012, Investigative ophthalmology & visual science.

[37]  David H. Sliney,et al.  The susceptibility of the retina to photochemical damage from visible light , 2012, Progress in Retinal and Eye Research.

[38]  K. Palczewski,et al.  Primary amines protect against retinal degeneration in mouse models of retinopathies , 2011, Nature chemical biology.

[39]  D. van Norren,et al.  The Action Spectrum of Photochemical Damage to the Retina: A Review of Monochromatic Threshold Data , 2011, Photochemistry and photobiology.

[40]  Junhua Zhang,et al.  C20-D3-vitamin A Slows Lipofuscin Accumulation and Electrophysiological Retinal Degeneration in a Mouse Model of Stargardt Disease* , 2010, The Journal of Biological Chemistry.

[41]  R. Crouch,et al.  Retinol dehydrogenases (RDHs) in the visual cycle. , 2010, Experimental eye research.

[42]  Ying Chen,et al.  Inhibition of the visual cycle by A2E through direct interaction with RPE65 and implications in Stargardt disease , 2010, Proceedings of the National Academy of Sciences.

[43]  K. Palczewski,et al.  The biochemical and structural basis for trans-to-cis isomerization of retinoids in the chemistry of vision. , 2010, Trends in biochemical sciences.

[44]  J. Sparrow,et al.  Phospholipid meets all-trans-retinal: the making of RPE bisretinoids , 2010, Journal of Lipid Research.

[45]  K. Palczewski,et al.  Involvement of All-trans-retinal in Acute Light-induced Retinopathy of Mice* , 2009, Journal of Biological Chemistry.

[46]  J. Sparrow,et al.  Photoreceptor cell degeneration in Abcr (-/-) mice. , 2009, Advances in experimental medicine and biology.

[47]  S. Jockusch,et al.  The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model , 2007, Proceedings of the National Academy of Sciences.

[48]  W. Baumeister,et al.  Three-dimensional architecture of murine rod outer segments determined by cryoelectron tomography , 2007, The Journal of cell biology.

[49]  K. Palczewski,et al.  Effects of Potent Inhibitors of the Retinoid Cycle on Visual Function and Photoreceptor Protection from Light Damage in Mice , 2006, Molecular Pharmacology.

[50]  T. Sarna,et al.  Light-induced Damage to the Retina: Role of Rhodopsin Chromophore Revisited , 2005, Photochemistry and photobiology.

[51]  P. Mukherjee,et al.  Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Jeyarajah,et al.  Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. , 2003, Journal of the American Society of Nephrology : JASN.

[53]  Farhad Hafezi,et al.  Protection of Rpe65-deficient mice identifies rhodopsin as a mediator of light-induced retinal degeneration , 2000, Nature Genetics.

[54]  S Berman,et al.  Retinal damage by light in rats. , 1966, Investigative ophthalmology.

[55]  P. Legrand,et al.  Comparative effects of dietary n-3 docosapentaenoic acid (DPA), DHA and EPA on plasma lipid parameters, oxidative status and fatty acid tissue composition. , 2019, The Journal of nutritional biochemistry.

[56]  J. Nickerson,et al.  A History of the Classical Visual Cycle. , 2015, Progress in molecular biology and translational science.

[57]  K. Palczewski,et al.  The ATP-binding cassette transporter ABCA4: structural and functional properties and role in retinal disease. , 2010, Advances in experimental medicine and biology.

[58]  M. Boulton,et al.  Retinal photodamage. , 2001, Journal of photochemistry and photobiology. B, Biology.